Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
OBIO

Updated 10/6/2026, 8:26 AM ET.

OBIO

Orchestra BioMed Holdings, Inc.

Sale$95,400

Sherman Darren

See Remarks, Director

15,000 shat $6.36Filed Oct 2, 4:30 PM ET
Filing
OBIO

Orchestra BioMed Holdings, Inc.

Buy$47,900

Hochman David P

See Remarks, Director

10,000 shat $4.79Filed Sep 8, 8:15 AM ETFiling
OBIO

Orchestra BioMed Holdings, Inc.

Sale$74,100

Sherman Darren

See Remarks, Director

15,000 shat $4.94Filed Sep 2, 4:15 PM ET
Filing
OBIO

Orchestra BioMed Holdings, Inc.

Buy$10,660

Sherman Darren

See Remarks, Director

2,000 shat $5.33Filed Aug 28, 4:15 PM ETFiling
OBIO

Orchestra BioMed Holdings, Inc.

Sale$61,350

Sherman Darren

See Remarks, Director

15,000 shat $4.09Filed Aug 4, 4:49 PM ET
Filing

Read from public SEC filings. Not financial advice.